<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200411047020N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-06-26</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The effect of faba bean extract on reduction of hairs of axilla</public_title>
      <acronym></acronym>
      <scientific_title>The effect of faba bean extract on reduction of hairs of axilla and Comparison with control group</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-05-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>19</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/47218</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: Evaluation of slow growth of hair in the axilla area is done monthly and 4 times (before the start of the intervention and then monthly for up to 3 months). by taking a photo with a Dermoscope or thrichoscope or take photos with high resolution cameras(In each individual, the axilla of one side is always intervention and the oppsite axilla is always control)  and comparing the axilla of both sides in each person, Randomization description: According to the random allocation made by Excel software or the randomization site, patients fall into two categories(even/odd code or A/B code).
one of the codes will be set to the right of the intervention axilla ,the left axilla of the placebo ,and the other code will be set to the right of the placebo    ,the left of the intervention, Blinding description: Each volunteer is given two containing bean extract and the other placebo.
neither the study person nor the evaluator is aware of the content of either of the two containers. the vessels are similar and it is not clear in which placebo and in which intervention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Reduce axilla hair with faba bean extract.</hc_freetext>
      <i_freetext>Intervention 1: In this study ،the effect of bean extract on reducing the thickness and number of  hairs in the axilla area will be investigated. 19 women 15 years and older who wish to participate in the study if they are not pregnant or breastfeeding ، have no history of laser use in this area ، have no inflammatory and infectious diseases and scar in this area and have no ٖٖٖG6PD enzyme deficiency enter the study and for 3 month of bean extract with a concentration of 20% in combination with base cream twice a day، one gr at a time، on one side and base cream is used as a placebo on the opposite side. And at the beginning of the study and at the end of each month for 3 months after three days of not shaving the hair of the erea ، both axillas are photographed with a tricoscope or camera. and at the end of the study، using a checklist of volunteers and photos taken ، the number and thickness of hair in two axillas per person will be compared .The cream containing bean extract is made in Mashhad medical sciences laboratory under the supervision of the relevant pharmacist. Intervention 2: Control group:In this study ,each person under study also has their own control.In exile, one side of the bean extract is used, and the opposite exile, the Base cream is used as a placebo as a control.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data can be shared after people have not been identified.

When:
Start the access period 6 months after printing the results.

To whom:
The data will be available to researchers working at academic and scientific  institutions.

Conditions:
Data analysis is allowded.

Where to obtain:
Email the author in charge of the article to receive the data.

How to obtain:
After the e-mail ، the requested information will be sent to the author and the request will be sent to them within a month.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Masood Maleki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dermatology clinic، Emamreza hospital، Daneshgah st، Mashhad</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913316</zip>
        <telephone>+98 51 3858 3845</telephone>
        <email>MalekiM@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Masood Maleki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dermatology clinic، Emamreza hospital، Daneshgah st، Mashhad</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913316</zip>
        <telephone>+98 51 3858 3845</telephone>
        <email>MalekiM@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>women 15 years of age and older who want to use this method to reduce unwanted hair in the area of the axilla.
Candidates who do not have a history of using laser in the axilla .</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Existence of skin disease in the area of axilla ,such as dermatitis and infectious and fungal diseases.
scarring in the area of the axilla.
G6PD deficiency in the test taken from people before the intervention.
pregnant women
Breastfeeding women</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>In this study ،the effect of bean extract on reducing the thickness and number of  hairs in the axilla area will be investigated. 19 women 15 years and older who wish to participate in the study if they are not pregnant or breastfeeding ، have no history of laser use in this area ، have no inflammatory and infectious diseases and scar in this area and have no ٖٖٖG6PD enzyme deficiency enter the study and for 3 month of bean extract with a concentration of 20% in combination with base cream twice a day، one gr at a time، on one side and base cream is used as a placebo on the opposite side. And at the beginning of the study and at the end of each month for 3 months after three days of not shaving the hair of the erea ، both axillas are photographed with a tricoscope or camera. and at the end of the study، using a checklist of volunteers and photos taken ، the number and thickness of hair in two axillas per person will be compared .The cream containing bean extract is made in Mashhad medical sciences laboratory under the supervision of the relevant pharmacist.</i_keyword>
      <i_keyword>Control group:In this study ,each person under study also has their own control.In exile, one side of the bean extract is used, and the opposite exile, the Base cream is used as a placebo as a control.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Axilla hair. Timepoint: Take a photo of the axilla area at the beginning of the study (Before starting the intervention) and 1,2and 3month after using the local bean extract. Method of measurement: thricoscope or camera(If it is not possible to use thricoscope).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-12-05</approval_date>
        <contact_name>Ethics committee of Mashhad university of Medical Sciences</contact_name>
        <contact_address>Vice chancellor for research and technology، Mashhad university،In frot of Daneshgah 18st، Daneshgah18، Mashhad Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
